Examples of using Atrial flutter in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
We have an atrial flutter.
Atrial flutter is often a precursor to atrial fibrillation.
Get her out of here. Atrial flutter again.
Atrial flutter is usually more organized and regular than atrial fibrillation.
Common: Bradycardia**; atrial flutter.
If atrial flutter is observed as secondary to treatment, continuation of infusion should be considered see section 4.2.
In both atrial fibrillation and atrial flutter this rhythm is disturbed and synchronization is lost between the atria and ventricles.
MULTAQ was to be used to treat patients with atrial fibrillation or atrial flutter.
She merely disrupted my atrial flutter and bradycardia.
Pediatric congenital cardiac abnormalities, atrial fibrillation versus atrial flutter.
If you have a heart rhythm where your heartbeat is very fast oruneven atrial fibrillation or atrial flutter.
Arrhythmia, QT prolongation, Atrial flutter, Ventricular extrasystoles.
On an electrocardiogram(ECG), which measures the electrical activity of the heart,a distinct pattern can be differentiated in atrial fibrillation and atrial flutter.
Uncommon: Angina pectoris,atrial fibrillation, atrial flutter, chest discomfort.
Myocardial ischemia, acute coronary syndrome, cardiac discomfort, ischemic cardiomyopathy, arteriospasm coronary,left ventricular dysfunction, atrial flutter.
Patients receiving BRINAVESS have a higher incidence of converting to atrial flutter within the first 2 hours post-dose.
Some patients with typical atrial flutter were included in ACT II and ACT III and BRINAVESS was not found to be effective in converting atrial flutter. .
BRINAVESS was not found to be effective in converting typical primary atrial flutter to sinus rhythm.
Ablation is used to treat most PSVTs, atrial flutter, atrial fibrillation, and some atrial and ventricular tachycardias.
Alert HCP for adverse reactions, which may occur after BRINAVESS administration,including hypotension, bradycardia, atrial flutter, or ventricular arrhythmia.
If haemodynamically stable atrial flutter is observed after the initial infusion, the second infusion of BRINAVESS may be administered as patients may convert to sinus rhythm see sections 4.4 and 4.8.
If the patient was in atrial fibrillation or atrial flutter at the end of the 15-minute observation period, a second 10-minute infusion of 2.0 mg/kg BRINAVESS(or matching placebo) was administered.
On 6 September 2006, sanofi-aventis officially notified the Committee for MedicinalProducts for Human Use(CHMP) that it wishes to withdraw its application for a marketing authorisation for MULTAQ, for the treatment of atrial fibrillation and atrial flutter.
